ANALYSIS: What now for EU medtech reforms?
This article was originally published in SRA
Executive Summary
So what's next for the proposals for a new regulatory framework for medical devices and in vitro diagnostics in the EU? And who will influence the way ahead? Amanda Maxwell looks at the views of the member states, the main stumbling blocks to further progress and how the cost of implementing the regulations is moving up the agenda.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.